Marksans Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

132.04

134.51

124.33

52.73

56.01

Net cashflow-operating activity

51.73

50.97

107.07

118.01

19.81

Net cash used in investing activity

-194.62

-8.40

8.82

-24.10

-20.20

Netcash used in fin. activity

210.02

75.86

-13.53

-92.29

0.96

Net inc/dec in cash and equivlnt

67.12

118.44

102.36

1.63

0.56

Cash and equivalnt begin of year

81.19

105.61

3.35

1.12

0.55

Cash and equivalnt end of year

148.31

224.05

105.71

2.75

1.12